等待开盘 01-01 09:30:00 美东时间
-0.480
-0.31%
今日重点评级关注:Truist Securities:维持拜玛林制药"买入"评级,目标价从80美元升至100美元;HC Wainwright & Co.:维持Savara"买入"评级,目标价从8美元升至10美元
2025-12-24 11:17
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
BTIG analyst Allan Verkhovski assumes Paylocity Holding (NASDAQ:PCTY) with a Buy rating and announces Price Target of $180.
2025-12-17 19:42
In today's rapidly changing and fiercely competitive business landscape, it is ...
2025-12-05 23:01
Goldman Sachs has identified a new group of “AI productivity beneficiaries,” highlighting companies best positioned to see earnings lift from automation-driven efficiency gains. Strategist David Kosti...
2025-11-18 21:52
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需关注的研究评级动态。 五大上调评级案例 诺斯兰(...
2025-11-10 22:53
Ratings for Paylocity Holding (NASDAQ:PCTY) were provided by 8 analysts in the ...
2025-11-10 19:45
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
2025-11-06 09:55
Citizens analyst Patrick Walravens maintains Paylocity Holding (NASDAQ:PCTY) with a Market Outperform and lowers the price target from $270 to $245.
2025-11-05 20:56